• 1
    Steinman, R. M., Dendritic cells: understanding immunogenicity. Eur. J. Immunol. 2007. 37: S53S60.
  • 2
    Jonuleit, H., Schmitt, E., Steinbrink, K. and Enk, A. H., Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 2001. 22: 394400.
  • 3
    Steinman, R. M. and Nussenzweig, M. C., Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 2002. 99: 351358.
  • 4
    Vosters, O., Neve, J., De Wit, D., Willems, F., Goldman, M. and Verhasselt, V., Dendritic cells exposed to nacystelyn are refractory to maturation and promote the emergence of alloreactive regulatory T cells. Transplantation 2003. 75: 383389.
  • 5
    Mahnke, K., Schmitt, E., Bonifaz, L., Enk, A. H. and Jonuleit, H., Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol. Cell Biol. 2002. 80: 477483.
  • 6
    Voigtlander, C., Rossner, S., Cierpka, E., Theiner, G., Wiethe, C., Menges, M., Schuler, G. and Lutz, M. B., Dendritic cells matured with TNF can be further activated in vitro and after subcutaneous injection in vivo which converts their tolerogenicity into immunogenicity. J Immunother 2006. 29: 407415.
  • 7
    Kleindienst, P., Wiethe, C., Lutz, M. B. and Brocker, T., Simultaneous induction of CD4 T cell tolerance and CD8 T cell immunity by semimature dendritic cells. J. Immunol. 2005. 174: 39413947.
  • 8
    Menges, M., Rossner, S., Voigtlander, C., Schindler, H., Kukutsch, N. A., Bogdan, C., Erb, K. et al., Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 2002. 195: 1521.
  • 9
    Sakaguchi, S., Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000. 101: 455458.
  • 10
    Shevach, E. M., CD4+CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2002. 2: 389400.
  • 11
    Fontenot, J. D., Gavin, M. A. and Rudensky, A. Y., Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003. 4: 330336.
  • 12
    Sakaguchi, S., Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004. 22: 531562.
  • 13
    Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Jakowlew, S., Alvarez-Mon, M., Derynck, R., Sporn, M. B. and Fauci, A. S., Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 1986. 163: 10371050.
  • 14
    Hoehn, P., Goedert, S., Germann, T., Koelsch, S., Jin, S., Palm, N., Ruede, E. and Schmitt, E., Opposing effects of TGF-beta 2 on the Th1 cell development of naive CD4+ T cells isolated from different mouse strains. J. Immunol. 1995. 155: 37883793.
  • 15
    Sad, S. and Mosmann, T. R., Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J. Immunol. 1994. 153: 35143522.
  • 16
    Ranges, G. E., Figari, I. S., Espevik, T. and Palladino, M. A., Jr., Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J. Exp. Med. 1987. 166: 991998.
  • 17
    Rao, P. E., Petrone, A. L. and Ponath, P. D., Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-beta. J. Immunol. 2005. 174: 14461455.
  • 18
    Zheng, S. G., Gray, J. D., Ohtsuka, K., Yamagiwa, S. and Horwitz, D. A., Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+ CD25 precursors. J. Immunol. 2002. 169: 41834189.
  • 19
    Chen, W., Jin, W., Hardegen, N., Lei, K. J., Li, L., Marinos, N., McGrady, G. and Wahl, S. M., Conversion of peripheral CD4+CD25 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 2003. 198: 18751886.
  • 20
    Fantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R. and Neurath, M. F., Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25 T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 2004. 172: 51495153.
  • 21
    Fu, S., Zhang, N., Yopp, A. C., Chen, D., Mao, M., Chen, D., Zhang, H. et al., TGF-beta induces Foxp3+T-regulatory cells from CD4+CD25 - precursors. Am. J. Transplant. 2004. 4: 16141627.
  • 22
    Chen, M. L., Pittet, M. J., Gorelik, L., Flavell, R. A., Weissleder, R., von Boehmer, H. and Khazaie, K., Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc. Natl. Acad. Sci. USA 2005. 102: 419424.
  • 23
    Gregg, R. K., Jain, R., Schoenleber, S. J., Divekar, R., Bell, J. J., Lee, H. H., Yu, P. and Zaghouani, H., A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes. J. Immunol. 2004. 173: 73087316.
  • 24
    Nakamura, K., Kitani, A. and Strober, W., Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 2001. 194: 629644.
  • 25
    Zhang, X., Moyana, T., Quereshi, M. and Xiang, J., Conversion of tolerogenic CD48- dendritic cells to immunogenic ones inducing efficient antitumor immunity. Cancer Biother. Radiopharm. 2006. 21: 7480.
  • 26
    Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M. C. and von Boehmer, H., Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 2005. 6: 12191227.
  • 27
    Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T. et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005. 201: 233240.
  • 28
    Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y. H., Wang, Y. et al., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005. 6: 11331141.
  • 29
    Lim, D. S., Kim, J. H., Lee, D. S., Yoon, C. H. and Bae, Y. S., DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors. Cancer Immunol. Immunother. 2007. 56: 18171829.
  • 30
    Rutella, S., Danese, S. and Leone, G., Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 2006. 108: 14351440.
  • 31
    Miossec, P., Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum. 2003. 48: 594601.
  • 32
    Nakae, S., Saijo, S., Horai, R., Sudo, K., Mori, S. and Iwakura, Y., IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 2003. 100: 59865990.
  • 33
    Liu, W., Putnam, A. L., Xu-Yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A. et al., CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+T reg cells. J. Exp. Med. 2006. 203: 17011711.
  • 34
    Knight, S. C., Iqball, S., Roberts, M. S., Macatonia, S. and Bedford, P. A., Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation. Eur. J. Immunol. 1998. 28: 16361644.
  • 35
    Bedford, P., Garner, K. and Knight, S. C., MHC class II molecules transferred between allogeneic dendritic cells stimulate primary mixed leukocyte reactions. Int. Immunol. 1999. 11: 17391744.
  • 36
    Lutz, M. B., Kukutsch, N., Ogilvie, A. L., Rossner, S., Koch, F., Romani, N. and Schuler, G., An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 1999. 223: 7792.
  • 37
    Tomita, T., Kakiuchi, Y. and Tsao, P. S., THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis. Arthritis Res. Ther. 2006. 8: R7.
  • 38
    Banda, N. K., Kraus, D., Vondracek, A., Huynh, L. H., Bendele, A., Holers, V. M. and Arend, W. P., Mechanisms of effects of complement inhibition in murine collagen-induced arthritis. Arthritis Rheum. 2002. 46: 30653075.
  • 39
    Tomita, T., Takeuchi, E., Tomita, N., Morishita, R., Kaneko, M., Yamamoto, K., Nakase, T. et al., Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum. 1999. 42: 25322542.